Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Your doctor has recommended a liver biopsy to check for a condition called NAFLD (fat buildup in the liver), based on specific medical findings
- An ultrasound scan has shown that there is fat in your liver
- You have at least one risk factor linked to liver disease, such as obesity, type 2 diabetes, or metabolic syndrome (a combination of conditions like high blood pressure, high blood sugar, and excess body fat)
- Your liver enzyme blood test results are above certain levels, OR your liver scarring score is high or in a middle range combined with signs of liver stiffness on a special scan
- You have agreed to take part in the study
Who may not be able to join:
- Anyone under 18 years of age
- People whose liver fat is caused by drinking moderate to large amounts of alcohol, or by certain medications known to affect the liver
- People who already have a known liver disease other than NAFLD, such as cirrhosis, viral hepatitis, autoimmune hepatitis, or a history of liver tumours
- People for whom a liver biopsy would not be safe — for example, due to fluid in the abdomen, low platelet counts, or certain abnormal blood clotting results (confirm with trial site)
- People who cannot have an MRI scan — for example, those with a pacemaker, severe claustrophobia, pregnancy, or certain metal implants that are not safe for MRI
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pierpaolo Pattacini, MD, Azienda USL - IRCCS di Reggio Emilia
Phone: +390522296369
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
False positives; False negatives; Sensitivity; Specificity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.